Sunday, August 28, 2005

Important Safety Information on Iressa (gefitinib) 250 mg Tablets

From Health Canada:
Health Canada recommends restricting the indication for IRESSA® to patients whose tumours are EGFR expression status positive or unknown......more
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)